News Sentiment

ABNX sentiment intelligence

ABIONYX Pharma SA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 58 Balanced news tone 2 relevant articles
Exchange PAR France
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.85 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Balance sheet

58/100 classification confidence.

Company focus 2

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-11.0% over one week, -31.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

ABIONYX Pharma: Half-Year Review of the Liquidity Agreement Entered into with TP ICAP (Europe) SA

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Balance sheet 58/100 classification
One-week reaction -11.0% Price reacting lower
Trend fit Trend inactive -31.8% over four weeks
Fair value -2.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 1
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 2
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 2

Event Lens

What the news is about

Classified themes
Balance sheet 1
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-2 of 2